TILRAY VENTURES LIMITED

Tilray Ventures Limited is a leading global developer, cultivator and supplier of medicinal cannabis, now authorised for prescription use in Ireland under the Medical Cannabis Access Programme. The company’s GMP‑certified facilities in Portugal – among the most advanced in the world – produce a broad portfolio of precisely formulated products, including whole‑flower, ground flower, oral solutions and purified capsules, each available in THC‑dominant, CBD‑dominant or balanced varieties.

Drawing on unrivalled experience across five continents, Tilray serves qualifying patients with conditions such as chemotherapy‑induced nausea and vomiting, multiple‑sclerosis‑related spasticity and severe refractory epilepsy. Their commitment to precision ensures every batch is tested for potency and purity, while rigorous research collaborations with leading hospitals and universities drive new clinical applications of cannabinoids.

In Ireland, Tilray works closely with consultant physicians and patient‑support teams to facilitate safe, monitored access to its medicines, reflecting a holistic approach that blends scientific rigour, compassionate care and a dedication to improving quality of life for patients nationwide.